FDA Orange Book · active-ingredient family
Indium in-111 oxyquinoline
Indium in-111 oxyquinoline is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:INDIUM IN 111 OXYQUINOLINE · NDA 019044
1
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INDIUM IN 111 OXYQUINOLINERLD | GE HEALTHCARE | NDA 019044 | AP | Dec 24, 1985 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INDIUM IN 111 OXYQUINOLINE | BWXT ITG | ANDA 202586 | AP | Jul 25, 2018 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Indium in-111 oxyquinoline — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
